Though Novavax is behind in the COVID-19 vaccine race, a blockbuster deal with Sanofi and a differentiated product means the ...

The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...

In light of recent statements by Opposition Leader Kamla Persad-Bissessar and Health Minister Terrence Deyalsingh regarding ...

The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the ...

Oxford Vaccine Rollout At the very end of December, UK healthcare regulator the Medicines and Healthcare Products Regulatory ...

With all these shots, some Canadians may have questions about the benefit of each vaccine, whether they should get every shot and how often to get them, and if it's safe to get them all at once or if ...

Epidemiologists and a federal health agency have criticized new COVID-19 guidance from Florida Surgeon General Joseph Ladapo as “dangerous” and a repeat of “misleading and false statements about COVID ...

The companies reported mixed results in their phase 3 trial of their mRNA vaccine, which includes antigens for influenza A and B, as well as the SARS-CoV-2 virus that causes COVID-19, and have ...

Researchers at multiple AViDD centers confirm that the NIH has offered a 1-year, no-cost extension, but it doesn’t come with ...

Imperial’s vaccine is the first one to trial saRNA against COVID-19, but other RNA-based vaccines are also in clinical trials for coronavirus, namely Moderna’s mRNA-1273 – already in late ...

In an era of increased strike activity and union power, labour experts say it's not surprising to see more calls for ...